Improving Outcomes in Mantle Cell Lymphoma

Approximately 6% of patients diagnosed with non-Hodgkin’s lymphoma have mantle cell lymphoma (MCL), which is typically associated with a bad prognosis. At this point, there is not a standard of care for MCL, and “optimal” treatment is dependent on where a patient is being treated, Myron S. Czuczman, MD, suggests.

Click here to continue reading this article at onclive.com

Share This

Newsletter Sign Up

Contact Lymphoma Australia Today!